Zoetis Inc (ZTS)
165.95
-1.12
(-0.67%)
USD |
NYSE |
May 06, 16:00
166.00
+0.05
(+0.03%)
Pre-Market: 20:00
Zoetis Revenue (TTM): 8.734B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.734B |
| December 31, 2023 | 8.544B |
| September 30, 2023 | 8.371B |
| June 30, 2023 | 8.222B |
| March 31, 2023 | 8.094B |
| December 31, 2022 | 8.08B |
| September 30, 2022 | 8.007B |
| June 30, 2022 | 7.995B |
| March 31, 2022 | 7.891B |
| December 31, 2021 | 7.776B |
| September 30, 2021 | 7.616B |
| June 30, 2021 | 7.412B |
| March 31, 2021 | 7.012B |
| December 31, 2020 | 6.675B |
| September 30, 2020 | 6.542B |
| June 30, 2020 | 6.34B |
| March 31, 2020 | 6.339B |
| December 31, 2019 | 6.26B |
| September 30, 2019 | 6.15B |
| June 30, 2019 | 6.046B |
| March 31, 2019 | 5.914B |
| December 31, 2018 | 5.825B |
| September 30, 2018 | 5.721B |
| June 30, 2018 | 5.588B |
| March 31, 2018 | 5.442B |
| Date | Value |
|---|---|
| December 31, 2017 | 5.307B |
| September 30, 2017 | 5.124B |
| June 30, 2017 | 5.018B |
| March 31, 2017 | 4.957B |
| December 31, 2016 | 4.888B |
| September 30, 2016 | 4.885B |
| June 30, 2016 | 4.858B |
| March 31, 2016 | 4.825B |
| December 31, 2015 | 4.765B |
| September 30, 2015 | 4.811B |
| June 30, 2015 | 4.807B |
| March 31, 2015 | 4.79B |
| December 31, 2014 | 4.785B |
| September 30, 2014 | 4.719B |
| June 30, 2014 | 4.612B |
| March 31, 2014 | 4.568B |
| December 31, 2013 | 4.561B |
| September 30, 2013 | 4.483B |
| June 30, 2013 | 4.399B |
| March 31, 2013 | 4.379B |
| December 31, 2012 | 4.336B |
| September 30, 2012 | 4.287B |
| June 30, 2012 | 4.317B |
| March 31, 2012 | 4.297B |
| December 31, 2011 | 4.233B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
6.046B
Minimum
Jun 2019
8.734B
Maximum
Mar 2024
7.405B
Average
7.696B
Median
Revenue (TTM) Benchmarks
| Biogen Inc | 9.663B |
| Pfizer Inc | 55.09B |
| Eli Lilly and Co | 35.93B |
| Bristol-Myers Squibb Co | 45.53B |
| Amgen Inc | 29.53B |